AUSTIN, Texas–(BUSINESS WIRE)– Apollo Endosurgery, Inc. (“Apollo”) (Nasdaq:APEN), a global leader in
less invasive medical devices for bariatric and gastrointestinal
procedures, today announced that the Company is scheduled to release its
financial results for the fourth quarter ended December 31, 2018 on
Monday, March 18, 2019, before the U.S. stock markets open.
Apollo will hold a conference call on Monday, March 18, 2019 at 7:30
a.m. CT / 8:30 a.m. ET to discuss the results. The dial-in numbers are
(877) 823-8673 for domestic callers and (647) 689-4156 for international
callers. The conference ID number is 3671589. A live webcast of the
conference call will be available online from the investor relations
page of the Company’s corporate website at www.apolloendo.com.
A replay of the webcast will be made available on Apollo’s website, www.apolloendo.com,
shortly after completion of the call.
About Apollo Endosurgery, Inc.
Apollo Endosurgery, Inc. is a medical technology company focused on less
invasive therapies to treat various gastrointestinal conditions, ranging
from gastrointestinal defect repairs to the interventional treatment of
obesity. Apollo’s device-based therapies are an alternative to invasive
surgical procedures, thus lowering complication rates and reducing total
healthcare costs. Apollo’s products are offered in over 70 countries
today and include the OverStitch™ Endoscopic Suturing System, the
OverStitch Sx™ Endoscopic Suturing System, and the ORBERA® Intragastric
Apollo’s common stock is traded on Nasdaq Global Market under the symbol
« APEN ». For more information regarding Apollo Endosurgery, go to: www.apolloendo.com.
Apollo Endosurgery, Inc.
John Gillings, 512-279-5100
Source: Apollo Endosurgery, Inc.